Clin2
NCT07753252Possibly a fitNot yet recruiting

How a new drug affects metformin levels in healthy adults

Healthy Participants

Treatments studied

This study tests a new drug called sevabertinib to see if it changes how the body handles metformin, a common diabetes medicine. It is for healthy adults and will help researchers understand if the two drugs can be taken together safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in good health overall.
  • You have not smoked or used nicotine products for at least 6 months.
  • Your body mass index (BMI) is between 18.5 and 30, and you weigh at least 50 kg (about 110 pounds).
  • If you are female, you cannot become pregnant (e.g., surgically sterilized or postmenopausal).
  • You are not taking regular medications, supplements, or herbal remedies (except vitamins) in the weeks before the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07862114Not yet recruiting· Phase 1
Testing drug interactions in healthy adults

This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.

NCT07300059Not yet recruiting· Phase 1
Testing liquid metformin versus standard tablets

This study compares how a liquid form of metformin, a common diabetes drug, affects blood sugar compared to standard tablets. It is for healthy adults to see if the liquid version works faster or differently.

NCT07300020Not yet recruiting· Phase 1
Comparing liquid metformin to tablets in healthy adults

This study compares a new liquid form of the diabetes medicine metformin to the standard pill, to see how well your body absorbs it. If you are a healthy adult, you may be able to help find out if this liquid version works as well as the tablet.

NCT07083401Recruiting· Phase 1
Study of a New Drug Combination in Healthy Adults

This trial tests how a new combination of drugs (BR3006A, BR3006B, and BR3006C) is absorbed and processed by the body when taken together, compared to a single tablet (BR3006). It is for healthy adults to understand the safety and behavior of the medication.

Seoul, Gwanak-gu
NCT07682233Recruiting· Phase 2
Study on a mitochondrial target and blood sugar control

This study tests a medicine called XBD173 to see how it affects blood sugar by targeting a protein inside cells' mitochondria. It may help people without diabetes learn about new ways to regulate blood sugar.

London
NCT07511010Not yet recruiting· Phase 1
Study of a diabetes drug combination in healthy adults

This study tests an investigational combination tablet for diabetes. It looks at how food affects the drug and how the body handles it when taken multiple times.

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.